1. Home
  2. CYCU vs PMVP Comparison

CYCU vs PMVP Comparison

Compare CYCU & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cycurion Inc.

CYCU

Cycurion Inc.

N/A

Current Price

$2.39

Market Cap

64.3M

Sector

N/A

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.28

Market Cap

72.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CYCU
PMVP
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.3M
72.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CYCU
PMVP
Price
$2.39
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
128.9K
★ 436.5K
Earning Date
11-16-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $17,771,485.00
N/A
Revenue This Year
$13.37
N/A
Revenue Next Year
$66.84
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.01
$1.02
52 Week High
$15.52
$1.91

Technical Indicators

Market Signals
Indicator
CYCU
PMVP
Relative Strength Index (RSI) 45.17 44.52
Support Level $0.03 $1.24
Resistance Level $2.77 $1.38
Average True Range (ATR) 0.26 0.11
MACD 0.05 -0.00
Stochastic Oscillator 49.35 47.06

Price Performance

Historical Comparison
CYCU
PMVP

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: